Global Antibody Drug Conjugates Market Analysis By Drugs , Pipeline Drugs, Regulations: Opportunities and Forecasts - By Region ; By Country

Thursday, April 13, 2017 Drug News
Email Print This Page Comment
Font : A-A+

LONDON, April 12, 2017 /PRNewswire/ -- Executive SummaryA comprehensive research report created through extensive

primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antibody Drug Conjugates Market on the basis of Analysis By Drug (Adcetris, Kadcyla), Pipeline Analysis
(Developer, Phase, Indication, Status, Cytotoxic Payload, Linker, Target), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Singapore, Brazil and South Africa).Download the full report: https://www.reportbuyer.com/product/4807875/Over the recent years, the global antibody drug conjugates industry has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs.According to Azoth Analytics research report, "Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)", global market is projected to display a robust growth represented by a CAGR of 21.82% during 2017 – 2022, chiefly driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates.Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few yearsThe report titled, "Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)", has covered and analysed the potential of Global Antibody Drug Conjugates Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.Scope of the ReportGlobal Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)- Antibody Drug Conjugates Market (ADC) Market- Adcetris Market- Kadcyla Market- ADC Pipeline - By Developer, Phase, Indication and Status- ADC Pipeline - By Cytotoxic Payload, Linker and TargetRegional Markets – N. America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022)- Antibody Drug Conjugates Market (ADC) Market- Adcetris Market- Kadcyla Market- ADC Pipeline - By Developer, Phase, Indication and Status- ADC Pipeline - By Cytotoxic Payload, Linker and TargetCountry Analysis - US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)- Antibody Drug Conjugates Market (ADC) MarketOther Report Highlights:- Market Dynamics – Trends, Drivers, Challenges- Porter's Five Forces Analysis- SWOT Analysis- Policy and Regulation- Company Analysis - Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics PharmaceuticalsCustomization of the ReportThe report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research. Download the full report: https://www.reportbuyer.com/product/4807875/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-antibody-drug-conjugates-market-analysis-by-drugs--pipeline-drugs-regulations-opportunities-and-forecasts---by-region--by-country-300438954.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook